Physician profile
Andrew Gaffney
NPI 1023367588
$4,289.80
in general payments reported to CMS, 2019-2025
15 companies · $2,197 in 2025
The $2,197 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $470 · 2022: $630 · 2023: $514 · 2024: $479 · 2025: $2,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Travel and Lodging: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.94 |
| Travel and Lodging | $702.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,581.92 | 2021-2025 | Watchman, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $710.37 | 2021-2025 | Cobalt Dr Mri Surescan, Affera Mapping System, Linq II |
| Pfizer INC. | $324.11 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $321.49 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $274.04 | 2021-2023 | |
| Cvrx, INC. | $252.39 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $239.06 | 2021-2025 | Amplatzer Amulet, Accent, Amplatzer Talisman |
| Atricure, INC. | $228.43 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Biotronik INC. | $189.02 | 2023-2025 | Amvia Edge, Biomonitor, Rivacor 7 Dr-T |
| Medicomp INC | $49.58 | 2025 | Telepatch Cardiac Monitor |
| Itamar Medical INC | $44.85 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.69 | 2021 | |
| Lundbeck LLC | $15.88 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.36 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Gaffney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.